American Century Companies Inc Nektar Therapeutics Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.64 - $3.15 $5,198 - $25,587	8,123 Added 22.05%	44,970 $31,000
Q4 2022 Feb 13, 2023	BUY	$2.03 - $4.28 $40,796 - $86,015	20,097 Added 119.98%	36,847 $83,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $50,920 - $86,095	16,750 New	16,750 $54,000
Q2 2018 Aug 08, 2018	SELL	$46.25 - $104.45 $4.12 Million - $9.3 Million	-89,050 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$57.4 - $108.44 $5.11 Million - $9.66 Million	89,050 New	89,050 $9.46 Million

152

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.